pressure alleviation pad, air, alternating contact, system
independent living specialists pty ltd - 38484 - pressure alleviation pad, air, alternating contact, system - pressure alleviation pad, air, alternating contact, system
pressure alleviation pad, air, alternating contact, system
novis healthcare pty ltd - 38484 - pressure alleviation pad, air, alternating contact, system - a system consisting of a pressure pad and a control unit, which is also the pump, designed to distribute pressure between the patient and the contact surface, e.g. the bed or chair, over a large surface by alternatively changing the pressure levels in the cells in the pressure pad. this reduces pressure on pressure points.
pressure alleviation pad, air, alternating contact, system
novis healthcare pty ltd - 38484 - pressure alleviation pad, air, alternating contact, system - a system consisting of a pressure pad and a control unit, which is also the pump, designed to distribute pressure between the patient and the contact surface, e.g. the bed or chair, over a large surface by alternatively changing the pressure levels in the cells in the pressure pad. this reduces pressure on pressure points.
pressure alleviation pad, air, alternating contact, <specify>
novis healthcare pty ltd -
38483 - pressure alleviation pad, air, alternating contact,
pressure alleviation pad, air, alternating contact, <specify>
novis healthcare pty ltd -
38483 - pressure alleviation pad, air, alternating contact,
acquired genetic alteration ivds
key diagnostics pty ltd - ct929 - acquired genetic alteration ivds - ivds that are intended to be used in genetic testing to provide information about acquired genetic alterations, which may include chromosomal alterations, mutations and/or alterations in gene expression, and which may be used to characterise haematological or solid tumour malignancies and/or provide prognostic information.the technology utilises pcr and reverse hybridisation.
acquired genetic alteration ivds
carl zeiss pty ltd - ct929 - acquired genetic alteration ivds - ivds that are intended to be used for fluorescent insitu hybridization (fish) to provide information about acquired genetic alterations, which may include chromosomal alterations, and which may be used to characterize hematological or solid tumor malignancies and/or provide prognostic information (ct929 acquired genetic alteration ivds). these products are intended for use as an adjunct to clinical and pathological information and not as independent tests or assays.
acquired genetic alteration ivds
agilent technologies australia pty ltd - ct929 - acquired genetic alteration ivds - the intended purpose is to determine acquired genetic alterations
acquired genetic alteration ivds - acquired genetic alteration ivds
abacus dx pty ltd - ct929 - acquired genetic alteration ivds - an in vitro medical device intended to be used in genetic testing to provide information about acquired genetic alternations, which may include chromosomal alterations, mutations and/or alterations in gene expression, and which may be used to characterise haematological or solid tumour malignancies and/or provide prognostic information.
acquired genetic alteration ivds - acquired genetic alteration ivds
abacus dx pty ltd - ct929 - acquired genetic alteration ivds - to be used in genetic testing to provide information about acquired genetic alterations